Company intelligence / Profile preview

OriGene Technologies

Rockville, Maryland, United States

Ownership: Private
Development stage: Other

Overview

OriGene does not conduct clinical research but has the industry's largest coverage of full-length human cDNAs and recombinant human proteins, supplying validated antibodies and proteins for research and diagnostics across genomics and proteomics[2][3][5].

Modalities: Recombinant proteinMonoclonal antibodyRecombinant monoclonal antibodyCRISPR/Cas9 gene editing reagentsLentiviral vectors
Industry: Chemicals & Materials

Beyond the preview

Go deeper on OriGene Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OriGene Technologies.

Explore the full profile